TEASE: A phase 2 clinical trial assessing the tolerability and effects of oral once-aday ALK-001 on stargardt disease

Category Primary study
JournalInvestigative Ophthalmology and Visual Science
Year 2016
This article has no abstract
Epistemonikos ID: 2240b9cf9b44a8d834df0c5113af7784c5ad045f
First added on: Feb 08, 2025